Auxly Cannabis Group Inc. XLY CBWTF released Monday its financial results for the three and six months ended June 30, 2023, revealing quarterly revenue of CA$22.0 million ($16.35 million) down by 8% sequentially and 20% year-over-year.
“We have successfully consolidated our dried flower and pre-roll cannabis product manufacturing, processing and distribution activities, which was a key strategic goal for this year,” Hugo Alves, CEO of Auxly stated. “While the transition had a temporary impact on the sales and financial performance during the quarter, we have already observed a positive impact of increased product throughput and improved product quality as a result of this consolidation. This is a part of a broader strategy to ensure Auxly can remain competitive against a backdrop of continued price compression and disproportionate taxation in the adult use recreational market. We believe that Auxly is well-positioned to compete in the current value-price driven environment given our brand portfolio, Auxly Leamington's cost structure and the automation investments we have made to our manufacturing processes.”
Q2 2023 Highlights
- Adjusted EBITDA was a loss of CA$1.1 million, an improvement of CA$2.9 million as compared to the same period last year.
- Net loss was CA$12.86 million, versus a net loss of CA$14.29 million in the same period of 2022.
- Gross profit was of CA$6.1 million, resulting in gross profit margin of 28%, compared to CA$9.8 million and 36% in second quarter of the prior year, respectively.
- Selling, general and administrative expenses declined by CA$1.3 million or 13% from the previous quarter and CA$4.1 million or 32% from the same period in 2022.
- As of June 30, Auxly held CA$8.56 million in cash and equivalents, CA$316,890 in assets, and had CA$174,201 million in debt.
Price Action
Auxly shares closed Friday market session 2.58% lower at $01.043 per share.
Benzinga Cannabis Capital Conference
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Photo: Courtesy of RDNE Stock project
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.